Medical paternalism and expensive unsubsidised drugs.
Jefford M., Savulescu J., Thomson J., Schofield P., Mileshkin L., Agalianos E., Zalcberg J.
When discussing treatment with patients, doctors may not mention newly licensed drugs that are not yet funded by healthcare schemes. Although their motives are good, the ethics are questionable